BioNexus Gene Lab Corp. (BGLC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
Tower B, Vertical Business Suite
Kuala Lumpur, 59200
Malaysia
Phone
60 1 2212 6512
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
30
First IPO Date
January 08, 2021
| Name | Title | Pay | Year Born |
| Su-Leng Tan | Chief Executive Officer, President, Secretary & Director | 446,019 | 1984 |
| Set Fui Chong | Chief Financial Officer | 42,268 | 1963 |
| Too Kam Tham | Managing Director | 0 | N/A |
| Kwan Wah Chan | Marketing Manager | 0 | N/A |
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.